The Biggest Pharmacogenomics Advances of 2025 — Year in Review
As 2025 comes to a close, pharmacogenomics has firmly stepped out of its former niche and into the spotlight as a research-driven catalyst…
-
-
Universal Basic Income 2045: What’s Pharmacogenomics Got To Do With It?
Everyone is Googling the future of work. With fingers crossed that their current “intelligent” role—knowledge worker, analyst, developer, scientist, consultant—won’t be the next…
-
AlphaFold and the Future of Precision Drugs
For decades, biology has faced a fundamental challenge: understanding how the information encoded in our genes translates into the physical machinery of life….
-
Is Pharmacogenomics Paired with AI the Antidote to the Global Cardiovascular Crisis?
Cardiovascular disease remains the world’s leading cause of death, claiming close to 20 million lives each year, with cases continuing to rise across…
-
Pharmacogenomics Is Transforming Drug Development and Patient Care: Insights from a Recent Study
Pharmacogenomics—the study of how an individual’s genetic makeup influences their response to medications—has become one of the most important pillars of modern personalized…
-
Machine Learning for pharmacogenomic variant effect predictions: Insights From a Recent Review
In the last decade, pharmacogenomics (PGx) has moved from a niche research domain into a central pillar of precision medicine. Sequencing is now…
-
Rethinking Pharmacogenomics with Multi-Omics and AI
For decades, doctors have relied on trial and error to prescribe medications. Two patients with the same condition can respond in completely opposite…
-
Vega, Sirius, &The Future of Pharmacogenomics
Drug prescribing is entering a new chapter. For decades, clinicians have relied on broad guidelines, trial-and-error approaches, and limited genetic information to determine…
-
OneOme to Shutdown, Deal a Blow to PGx Industry Momentum
OneOme, a leading name in pharmacogenomics testing and personalized medicine, has announced that it will cease operations by November 14, 2025, citing ongoing…
-
The Three Key Factors Driving the Rise of Preemptive Pharmacogenomics
For years, pharmacogenomics (PGx) was seen as a future promise, a fascinating science that could someday make drug therapy safer and more effective….
End of content
End of content